Key result
Polymeric transcatheter valve shows favorable 1-year hemodynamics and zero hypoattenuated leaflet thickening in first-in-human data.
Why the study?
Valve durability remains the most critical unresolved challenge as TAVR expands to younger and lower-risk patients with longer life expectancy, with limited long-term data beyond 10 to 15 years for contemporary transcatheter heart valves.
Answers are grounded in this paper and cite their sources.
Supports early development of polymeric valves; leaves open durability, safety, and efficacy in larger randomized cohorts.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Shirai et al. (2026) conducted an editorial in Severe aortic stenosis. Sikelia fully polymeric transcatheter heart valve vs. None (single arm) was evaluated. The Sikelia fully polymeric transcatheter heart valve demonstrated favorable 1-year hemodynamics, improvements in functional capacity, and a complete absence of hypoattenuated leaflet thickening in a first-in-human study.
Synapse has enriched 10 related papers. Consider them for comparative context: